AE Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

AE Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Buy	1,006 +128	+15%	+$13.2K	﹤0.01%	1888
2026 Q1	$91.2K	Hold	878	–	–	﹤0.01%	1825
2025 Q4	$90.6K	Sell	878 -123	-12%	-$12K	﹤0.01%	1725
2025 Q3	$90.5K	Sell	1,001 -3	-0.3%	-$263	﹤0.01%	1595
2025 Q2	$88.3K	Sell	1,004 -42	-4%	-$3.64K	﹤0.01%	1511
2025 Q1	$95.3K	Buy	1,046 +567	+118%	+$51.1K	﹤0.01%	1453
2024 Q4	$41.3K	Buy	+479	New	+$43.3K	﹤0.01%	1590
2022 Q4	–	Sell	-3,282	Closed	-$221K	–	1894
2022 Q3	$221K	Sell	3,282 -208	-6%	-$15.3K	﹤0.01%	1584
2022 Q2	$268K	Buy	+3,490	New	+$272K	﹤0.01%	1482

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

AE Wealth Management's PPH Position: Q2 2026 in Review

AE Wealth Management increased its VanEck Pharmaceutical ETF (PPH) stake by 15% in Q2 2026, buying an estimated $13.2K and bringing the position to 1,006 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

AE Wealth Management first reported a position in PPH in Q2 2022 and has held it in 9 quarters since. The position peaked at $268K in Q2 2022. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

AE Wealth Management held 1,006 shares of VanEck Pharmaceutical ETF worth $110K as of Q2 2026.
AE Wealth Management bought 128 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $13.2K.
VanEck Pharmaceutical ETF made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #1888 holding.
AE Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and has held it in 9 quarters since.
AE Wealth Management's VanEck Pharmaceutical ETF position peaked at $268K in Q2 2022.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.